GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for mitochondrial intermediate peptidase (A7TSL2)

Analyse AlphaFold monomer V2.0 prediction for mitochondrial intermediate peptidase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A7TSL2
Type
protein
Length
787 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x6DAA77C4263E74E745cA9c4D8E291e57e8991Cf5
Molecule
Mitochondrial intermediate peptidase
UniProt
A7TSL2
Pockets
10 · best druggability 0.85

Structure

1 distinct chain · 57% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitochondrial intermediate peptidaseprotein78757% helix, 9% strandA7TSL2

Pockets

10 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110590.850.8691empty
2770.720.9622empty
3600.720.9819empty
41400.620.8626empty
52250.580.7940empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.